Lion Point Capital, Lp Top Holdings and 13F Report (2021) About Lion Point Capital, LpInvestment ActivityLion Point Capital, Lp has $19.10 million in total holdings as of September 30, 2021.Lion Point Capital, Lp owns shares of 19 different stocks, but just 12 companies or ETFs make up 80% of its holdings.Approximately 7.36% of the portfolio was purchased this quarter.About 139.08% of the portfolio was sold this quarter.This quarter, Lion Point Capital, Lp has purchased 25 new stocks and bought additional shares in 4 stocks.Lion Point Capital, Lp sold shares of 8 stocks and completely divested from 7 stocks this quarter.Largest Holdings Insmed $2,533,768Milestone Pharmaceuticals $2,420,902Geron $1,770,000Ardelyx $1,700,478Fennec Pharmaceuticals $1,236,824 Largest New Holdings this Quarter 09609G209 - BLUEBIRD BIO INC $658,126 Holding Largest Purchases this Quarter BLUEBIRD BIO INC 78,912 shares (about $658.13K)BENITEC BIOPHARMA INC 23,000 shares (about $290.49K)Disc Medicine 2,900 shares (about $183.86K)Arcutis Biotherapeutics 11,200 shares (about $156.02K)Syndax Pharmaceuticals 8,800 shares (about $116.34K) Largest Sales this Quarter Milestone Pharmaceuticals 628,348 shares (about $1.48M)Insmed 15,500 shares (about $1.07M)Biohaven 12,700 shares (about $474.35K)Geron 130,000 shares (about $460.20K)KINIKSA PHARMACEUTICALS LTD 15,500 shares (about $306.59K) Sector Allocation Over TimeMap of 500 Largest Holdings ofLion Point Capital, Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorINSMInsmed$2,533,768$1,070,120 ▼-29.7%36,70013.3%MedicalMISTMilestone Pharmaceuticals$2,420,902$1,482,901 ▼-38.0%1,025,80612.7%MedicalGERNGeron$1,770,000$460,200 ▼-20.6%500,0009.3%MedicalARDXArdelyx$1,700,478$175,422 ▼-9.4%335,4008.9%MedicalFENCFennec Pharmaceuticals$1,236,824$121,976 ▼-9.0%195,7006.5%MedicalBBIOBridgeBio Pharma$1,105,832$238,728 ▼-17.8%40,3005.8%MedicalMLYSMineralys Therapeutics$972,4900.0%79,0005.1%MedicalKINIKSA PHARMACEUTICALS LTD$907,902$306,590 ▼-25.2%45,9004.8%ORD SHS CL ABHVNBiohaven$847,845$474,345 ▼-35.9%22,7004.4%MedicalBENITEC BIOPHARMA INC$783,060$290,490 ▲59.0%62,0004.1%COM NEWSNDXSyndax Pharmaceuticals$727,100$116,336 ▲19.0%55,0003.8%MedicalJASPER THERAPEUTICS INC$684,1600.0%32,0003.6%COM NEWAVADEL PHARMACEUTICALS PLC$672,6400.0%64,0003.5%COM SHSIRONDisc Medicine$672,040$183,860 ▲37.7%10,6003.5%MedicalBLUEBIRD BIO INC$658,126$658,126 ▲New Holding78,9123.4%COM NEWARQTArcutis Biotherapeutics$644,959$156,016 ▲31.9%46,3003.4%MedicalRGNXREGENXBIO$446,4080.0%57,7502.3%MedicalMCRBSeres Therapeutics$283,1720.0%340,7611.5%MedicalSPRBSpruce Biosciences$31,5000.0%75,0000.2%MedicalIWMiShares Russell 2000 ETF$0$18,223,425 ▼-100.0%00.0%FinanceMIRMMirum Pharmaceuticals$0$1,755,000 ▼-100.0%00.0%MedicalMRNSMarinus Pharmaceuticals$0$1,221,049 ▼-100.0%00.0%MedicalBLUEbluebird bio$0$819,904 ▼-100.0%00.0%MedicalLUMOLumos Pharma$0$153,209 ▼-100.0%00.0%MedicalMSFTMicrosoft$0$43,030 ▼-100.0%00.0%Computer and TechnologyGOOGAlphabet$0$16,719 ▼-100.0%00.0%Computer and TechnologyShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
